|
1
|
McDowell JD: An overview of epidemiology
and common risk factors for oral squamous cell carcinoma.
Otolaryngol Clin North Am. 39:277–294. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Williams HK: Molecular pathogenesis of
oral squamous carcinoma. Mol Pathol. 53:165–172. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Bernier J, Domenge C, Ozsahin M,
Matuszewska K, Lefèbvre JL, Greiner RH, Giralt J, Maingon P,
Rolland F, Bolla M, et al: Postoperative irradiation with or
without concomitant chemotherapy for locally advanced head and neck
cancer. N Engl J Med. 350:1945–1952. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Warnakulasuriya S: Global epidemiology of
oral and oropharyngeal cancer. Oral Oncol. 45:309–316. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Wolf GT, Chepeha DB, Bellile E, Nguyen A,
Thomas D and McHugh J; University of Michigan Head and Neck SPORE
Program, : Tumor infiltrating lymphocytes (TIL) and prognosis in
oral cavity squamous carcinoma: A preliminary study. Oral Oncol.
51:90–95. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Watanabe Y, Katou F, Ohtani H, Nakayama T,
Yoshie O and Hashimoto K: Tumor-infiltrating lymphocytes,
particularly the balance between CD8(+) T cells and CCR4(+)
regulatory T cells, affect the survival of patients with oral
squamous cell carcinoma. Oral Surg Oral Med Oral Pathol Oral Radiol
Endod. 109:744–752. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Piersma SJ, Jordanova ES, van Poelgeest
MI, Kwappenberg KM, van der Hulst JM, Drijfhout JW, Melief CJ,
Kenter GG, Fleuren GJ, Offringa R and van der Burg SH: High number
of intraepithelial CD8+ tumor-infiltrating lymphocytes is
associated with the absence of lymph node metastases in patients
with large early-stage cervical cancer. Cancer Res. 67:354–361.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Wolf D, Wolf AM, Rumpold H, Fiegl H,
Zeimet AG, Muller-Holzner E, Deibl M, Gastl G, Gunsilius E and
Marth C: The expression of the regulatory T cell-specific forkhead
box transcription factor FoxP3 is associated with poor prognosis in
ovarian cancer. Clin Cancer Res. 11:8326–8331. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Sato E, Olson SH, Ahn J, Bundy B,
Nishikawa H, Qian F, Jungbluth AA, Frosina D, Gnjatic S, Ambrosone
C, et al: Intraepithelial CD8+ tumor-infiltrating lymphocytes and a
high CD8+/regulatory T cell ratio are associated with favorable
prognosis in ovarian cancer. Proc Natl Acad Sci USA.
102:18538–18543. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Gao Q, Qiu SJ, Fan J, Zhou J, Wang XY,
Xiao YS, Xu Y, Li YW and Tang ZY: Intratumoral balance of
regulatory and cytotoxic T cells is associated with prognosis of
hepatocellular carcinoma after resection. J Clin Oncol.
25:2586–2593. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Jordanova ES, Gorter A, Ayachi O, Prins F,
Durrant LG, Kenter GG, van der Burg SH and Fleuren GJ: Human
leukocyte antigen class I, MHC class I chain-related molecule A,
and CD8+/regulatory T-cell ratio: Which variable determines
survival of cervical cancer patients? Clin Cancer Res.
14:2028–2035. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Kryczek I, Lange A, Mottram P, Alvarez X,
Cheng P, Hogan M, Moons L, Wei S, Zou L, Machelon V, et al: CXCL12
and vascular endothelial growth factor synergistically induce
neoangiogenesis in human ovarian cancers. Cancer Res. 65:465–472.
2005.PubMed/NCBI
|
|
13
|
Orimo A, Gupta PB, Sgroi DC,
Arenzana-Seisdedos F, Delaunay T, Naeem R, Carey VJ, Richardson AL
and Weinberg RA: Stromal fibroblasts present in invasive human
breast carcinomas promote tumor growth and angiogenesis through
elevated SDF-1/CXCL12 secretion. Cell. 121:335–348. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Edge SB and Compton CC: The American Joint
Committee on Cancer: The 7th edition of the AJCC cancer staging
manual and the future of TNM. Ann Surg Oncol. 17:1471–1474. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Xia J, Chen N, Hong Y, Chen X, Tao X,
Cheng B and Huang Y: Expressions of CXCL12/CXCR4 in oral
premalignant and malignant lesions. Mediators Inflamm.
2012:5163952012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Liu F, Lang R, Zhao J, Zhang X, Pringle
GA, Fan Y, Yin D, Gu F, Yao Z and Fu L: CD8+ cytotoxic T
cell and FOXP3+ regulatory T cell infiltration in
relation to breast cancer survival and molecular subtypes. Breast
Cancer Res Treat. 130:645–655. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Rabinovich GA, Gabrilovich D and Sotomayor
EM: Immunosuppressive strategies that are mediated by tumor cells.
Annu Rev Immunol. 25:267–296. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Clatot F, Picquenot JM, Choussy O,
Gouérant S, Moldovan C, Schultheis D, Cornic M, François A, Blot E
and Laberge-Le-Couteulx S: Intratumoural level of SDF-1 correlates
with survival in head and neck squamous cell carcinoma. Oral Oncol.
47:1062–1068. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Strauss L, Bergmann C, Szczepanski M,
Gooding W, Johnson JT and Whiteside TL: A unique subset of
CD4+CD25highFoxp3+ T cells secreting interleukin-10 and
transforming growth factor-beta1 mediates suppression in the tumor
microenvironment. Clin Cancer Res. 13:4345–4354. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Whiteside TL: The tumor microenvironment
and its role in promoting tumor growth. Oncogene. 27:5904–5912.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Nguyen N, Bellile E, Thomas D, McHugh J,
Rozek L, Virani S, Peterson L, Carey TE, Walline H, Moyer J, et al:
Tumor infiltrating lymphocytes and survival in patients with head
and neck squamous cell carcinoma. Head Neck. 38:1074–1084. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Halama N, Michel S, Kloor M, Zoernig I,
Benner A, Spille A, Pommerencke T, von Knebel DM, Folprecht G,
Luber B, et al: Localization and density of immune cells in the
invasive margin of human colorectal cancer liver metastases are
prognostic for response to chemotherapy. Cancer Res. 71:5670–5677.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Badoual C, Hans S, Rodriguez J, Peyrard S,
Klein C, Agueznay Nel H, Mosseri V, Laccourreye O, Bruneval P,
Fridman WH, et al: Prognostic value of tumor-infiltrating CD4+
T-cell subpopulations in head and neck cancers. Clin Cancer Res.
12:465–472. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Zou L, Barnett B, Safah H, Larussa VF,
Evdemon-Hogan M, Mottram P, Wei S, David O, Curiel TJ and Zou W:
Bone marrow is a reservoir for CD4+CD25+ regulatory T cells that
traffic through CXCL12/CXCR4 signals. Cancer Res. 64:8451–8455.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Obermajer N, Muthuswamy R, Odunsi K,
Edwards RP and Kalinski P: PGE(2)-induced CXCL12 production and
CXCR4 expression controls the accumulation of human MDSCs in
ovarian cancer environment. Cancer Res. 71:7463–7470. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zboralski D, Hoehlig K, Eulberg D,
Frömming A and Vater A: increasing tumor-infiltrating T cells
through inhibition of CXCL12 with NOX-A12 synergizes with PD-1
blockade. Cancer Immunol Res. 5:950–956. 2017. View Article : Google Scholar : PubMed/NCBI
|
